These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11518784)

  • 1. In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1.
    Salama AD; Chaudhry AN; Ryan JJ; Eren E; Levy JB; Pusey CD; Lightstone L; Lechler RI
    J Am Soc Nephrol; 2001 Sep; 12(9):1908-1915. PubMed ID: 11518784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Goodpasture antigen is expressed in the human thymus.
    Wong D; Phelps RG; Turner AN
    Kidney Int; 2001 Nov; 60(5):1777-83. PubMed ID: 11703595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
    Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD
    J Am Soc Nephrol; 2005 May; 16(5):1350-9. PubMed ID: 15814836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences.
    Phelps RG; Jones VL; Coughlan M; Turner AN; Rees AJ
    J Biol Chem; 1998 May; 273(19):11440-7. PubMed ID: 9565555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthy individuals have Goodpasture autoantigen-reactive T cells.
    Zou J; Hannier S; Cairns LS; Barker RN; Rees AJ; Turner AN; Phelps RG
    J Am Soc Nephrol; 2008 Feb; 19(2):396-404. PubMed ID: 18216317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.
    Ooi JD; Holdsworth SR; Kitching AR
    J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease.
    Cairns LS; Phelps RG; Bowie L; Hall AM; Saweirs WW; Rees AJ; Barker RN
    J Am Soc Nephrol; 2003 Nov; 14(11):2801-12. PubMed ID: 14569090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of T cell responses to the autoantigen in Goodpasture's disease.
    Derry CJ; Ross CN; Lombardi G; Mason PD; Rees AJ; Lechler RI; Pusey CD
    Clin Exp Immunol; 1995 May; 100(2):262-8. PubMed ID: 7743665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis.
    Reynolds J; Haxby J; Juggapah JK; Evans DJ; Pusey CD
    Clin Exp Immunol; 2009 Feb; 155(2):311-9. PubMed ID: 19040602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central tolerance regulates B cells reactive with Goodpasture antigen alpha3(IV)NC1 collagen.
    Zhang Y; Su SC; Hecox DB; Brady GF; Mackin KM; Clark AG; Foster MH
    J Immunol; 2008 Nov; 181(9):6092-100. PubMed ID: 18941198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
    Ryan JJ; Mason PJ; Pusey CD; Turner N
    Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome.
    MacDonald BA; Sund M; Grant MA; Pfaff KL; Holthaus K; Zon LI; Kalluri R
    Blood; 2006 Mar; 107(5):1908-15. PubMed ID: 16254142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
    Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
    J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN.
    Ooi JD; Chang J; O'Sullivan KM; Pedchenko V; Hudson BG; Vandenbark AA; Fugger L; Holdsworth SR; Kitching AR
    J Am Soc Nephrol; 2013 Feb; 24(3):419-31. PubMed ID: 23411782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic peptides of Goodpasture's antigen in antiglomerular basement membrane nephritis in rats.
    Luo AM; Fox JW; Chen L; Bolton WK
    J Lab Clin Med; 2002 May; 139(5):303-10. PubMed ID: 12032491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease.
    Yang R; Cui Z; Hellmark T; Segelmark M; Zhao MH; Wang HY
    Clin Immunol; 2007 Aug; 124(2):207-12. PubMed ID: 17556023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with alpha3 chain of type IV collagen.
    Abbate M; Kalluri R; Corna D; Yamaguchi N; McCluskey RT; Hudson BG; Andres G; Zoja C; Remuzzi G
    Kidney Int; 1998 Nov; 54(5):1550-61. PubMed ID: 9844131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor.
    Dougan T; Levy JB; Salama A; George AJ; Pusey CD
    Clin Exp Immunol; 2002 Jun; 128(3):555-61. PubMed ID: 12067312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen.
    Kalluri R; Sun MJ; Hudson BG; Neilson EG
    J Biol Chem; 1996 Apr; 271(15):9062-8. PubMed ID: 8621555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
    Borza DB; Hudson BG
    Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.